Jun 27, 2024

Hey there,

I’m excited to share some great news in the healthcare industry! First off, Malaysia’s health expenditure is expected to grow by 8.3% CAGR until 2028, making it one of the fastest-growing in the ASEAN region. Additionally, Kuwait’s Vision 2035 development plan is driving healthcare expenditure, with the country’s health spending per capita reaching above the global median. The hospital infection therapeutics market is also on the rise, expected to grow by $3.46 billion amidst the increasing prevalence of HAIs.

In India, the Asian Development Bank has approved a $170 million loan to strengthen the country’s health systems, in support of the government’s National Health Policy 2017. Omega Hospitals has adopted a robotic system for targeted radiation therapy, promoting precise cancer treatment with minimal side effects. Furthermore, the global neuromodulation market is expected to witness a 12.57% CAGR growth within the forecast period.

Moving on to the U.S., the response to the bird flu has been identified as deeply flawed, with experts and officials highlighting insufficient testing infrastructure and incomplete understanding of the virus spread. The CDC has also issued a warning on the higher risk of contracting dengue virus in the U.S. this year, with countries in North and South America reporting twice as many cases as in 2023.

In other news, the visa freeze for foreign-educated nurses in the U.S. is limiting one potential fix for the country’s stark shortage of healthcare workers. However, there are efforts to reclaim unused green card slots and make additional employment-based visas available for nurses. This could help tap into a global talent pool and bolster the nursing workforce, especially in rural areas.

Overall, these developments indicate promising advancements and opportunities in the healthcare sector. Stay tuned for more positive updates in the future!

Best,

Summy

Stay Well!